Published in N Engl J Med on February 23, 1995
Mechanism of injury-provoked poliomyelitis. J Virol (1998) 1.13
A nonpolio enterovirus with respiratory tropism causes poliomyelitis in intercellular adhesion molecule 1 transgenic mice. Proc Natl Acad Sci U S A (2004) 1.06
Limited trafficking of a neurotropic virus through inefficient retrograde axonal transport and the type I interferon response. PLoS Pathog (2010) 1.06
Innate host barriers to viral trafficking and population diversity: lessons learned from poliovirus. Adv Virus Res (2010) 0.96
Comparison of three neurotropic viruses reveals differences in viral dissemination to the central nervous system. Virology (2015) 0.82
Dynamic ubiquitination drives herpesvirus neuroinvasion. Proc Natl Acad Sci U S A (2015) 0.80
History of polio vaccination. World J Virol (2012) 0.78
A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus. J Virol (2016) 0.75
Minimizing the risks associated with the prevention of poliomyelitis. N Engl J Med (1995) 0.75
Intramuscular injections and vaccine-associated poliomyelitis. N Engl J Med (1995) 0.75
Intramuscular injections and vaccine-associated poliomyelitis. N Engl J Med (1995) 0.75
Polio, still lurking in the shadows. J Neurosci (2013) 0.75
Pasteurized milk as a vehicle of infection in an outbreak of listeriosis. N Engl J Med (1985) 11.94
Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA (1993) 4.63
A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med (1995) 4.21
Cost-effectiveness of a routine varicella vaccination program for US children. JAMA (1994) 3.27
Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta. JAMA (1991) 3.09
Current situation and control strategies for resurgence of diphtheria in newly independent states of the former Soviet Union. Lancet (1996) 2.78
Impact of measurement and feedback on vaccination coverage in public clinics, 1988-1994. JAMA (1997) 2.74
Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet (1991) 2.64
Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis (1992) 2.55
Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol (1998) 2.24
Fatal respiratory disease due to Corynebacterium diphtheriae: case report and review of guidelines for management, investigation, and control. Clin Infect Dis (1993) 2.21
Differential diagnosis of acute flaccid paralysis and its role in poliomyelitis surveillance. Epidemiol Rev (2000) 2.06
Risk factors for West Nile virus infection and meningoencephalitis, Romania, 1996. J Infect Dis (1999) 2.03
The Vaccine Adverse Event Reporting System (VAERS). Vaccine (1994) 2.02
Stopping poliovirus vaccination after eradication: issues and challenges. Bull World Health Organ (2000) 2.00
Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States. JAMA (1996) 1.93
Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment. JAMA (1985) 1.91
Measles herd immunity. The association of attack rates with immunization rates in preschool children. JAMA (1992) 1.85
Acquired immunodeficiency syndrome in low-incidence areas. How safe is unsafe sex? JAMA (1987) 1.81
Pertussis hospitalizations and mortality in the United States, 1985-1988. Evaluation of the completeness of national reporting. JAMA (1992) 1.74
The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. Cancer and Steroid Hormone Study Group. J Clin Epidemiol (1989) 1.68
Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review. Clin Infect Dis (2000) 1.67
Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2000) 1.67
Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule. JAMA (1996) 1.64
Childhood upper respiratory tract infections: to what degree is incidence affected by day-care attendance? Pediatrics (1987) 1.57
Epidemiological features of pertussis in the United States, 1980-1989. Clin Infect Dis (1992) 1.55
Reporting efficiency during a measles outbreak in New York City, 1991. Am J Public Health (1993) 1.53
Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication. Int J Epidemiol (2001) 1.53
Measles epidemic in Romania, 1996-1998: assessment of vaccine effectiveness by case-control and cohort studies. Am J Epidemiol (1999) 1.48
Comment: ethical dilemmas in worldwide polio eradication programs. Am J Public Health (1997) 1.44
Primary invasive Haemophilus influenzae type b disease: a population-based assessment of risk factors. J Pediatr (1986) 1.40
Vaccine-associated paralytic poliomyelitis. N Engl J Med (1993) 1.39
Outbreak of paralytic poliomyelitis in Albania, 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccination. Clin Infect Dis (1998) 1.38
Mumps outbreak in a highly vaccinated population. J Pediatr (1991) 1.30
Vaccine prevention of Haemophilus influenzae type b disease: past, present and future. Pediatr Infect Dis (1986) 1.27
Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease. Arch Pediatr Adolesc Med (1994) 1.23
Outbreaks of paralytic poliomyelitis, 1976-1995. J Infect Dis (1997) 1.20
Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. Am J Epidemiol (1994) 1.20
Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication. Clin Infect Dis (2001) 1.20
Disease eradication as a public health strategy: a case study of poliomyelitis eradication. Bull World Health Organ (2000) 1.18
Assessment of vital statistics and surveillance data for monitoring tetanus mortality, United States, 1979-1984. Am J Epidemiol (1990) 1.18
Mumps transmission in hospitals. Arch Intern Med (1990) 1.14
Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccination. Am J Epidemiol (2001) 1.13
National immunization days: state of the art. J Infect Dis (1997) 1.12
Measles eradication: is it in our future? Am J Public Health (2000) 1.12
Preventing rubella: assessing missed opportunities for immunization. Am J Public Health (1987) 1.11
Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection. Am J Epidemiol (1994) 1.09
Tetanus surveillance--United States, 1989-1990. MMWR CDC Surveill Summ (1992) 1.09
A large outbreak of mumps in the postvaccine era. J Infect Dis (1988) 1.08
Mumps in the workplace. Further evidence of the changing epidemiology of a childhood vaccine-preventable disease. JAMA (1988) 1.07
Immunizations in college health: the remaining tasks. J Am Coll Health (1987) 1.06
Measles antibody in vaccinated human immunodeficiency virus type 1-infected children. Pediatrics (1996) 1.02
Husband's approval of contraceptive use in metropolitan Indonesia: program implications. Stud Fam Plann (1988) 1.01
Prevention of secondary transmission of pertussis in households with early use of erythromycin. Am J Dis Child (1992) 1.01
Pertussis surveillance--United States, 1989-1991. MMWR CDC Surveill Summ (1992) 1.01
Vaccine-associated paralytic poliomyelitis and HIV infection. Lancet (1994) 1.00
Control of epidemic group A meningococcal meningitis in Nepal. Int J Epidemiol (1987) 0.98
Pertussis in Missouri: evaluation of nasopharyngeal culture, direct fluorescent antibody testing, and clinical case definitions in the diagnosis of pertussis. Clin Infect Dis (1993) 0.97
Secondary Haemophilus influenzae type b in day-care facilities. Risk factors and prevention. JAMA (1985) 0.96
Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: poliovirus vaccination. Ann N Y Acad Sci (1995) 0.96
Overview of neonatal listeriosis. Clin Invest Med (1984) 0.95
Concurrent outbreaks of pertussis and Mycoplasma pneumoniae infection: clinical and epidemiological characteristics of illnesses manifested by cough. Clin Infect Dis (1995) 0.95
An evaluation of measles revaccination among school-entry-aged children. Pediatrics (1996) 0.94
Changing epidemiology of mumps and its impact on university campuses. Pediatrics (1989) 0.93
Risk factors for pertussis in young infants during an outbreak in Chicago in 1993. Clin Infect Dis (1996) 0.93
Vaccination practices, policies, and management factors associated with high vaccination coverage levels in Georgia public clinics. Georgia Immunization Program Evaluation Team. Arch Pediatr Adolesc Med (2000) 0.92
Waving goodbye to measles. Nature (2001) 0.91
The geographic distribution of measles in the United States, 1980 through 1989. JAMA (1992) 0.91
A study evaluating poliovirus antibodies and risk factors associated with polio seropositivity in low socioeconomic areas of Pakistan. Vaccine (2013) 0.90
A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases. Am J Public Health (1989) 0.89
Tetanus surveillance--United States, 1991-1994. MMWR CDC Surveill Summ (1997) 0.89
Increased susceptibility to measles in infants in the United States. Pediatrics (1999) 0.86
Estimating national incidence of group B streptococcal disease: the effect of adjusting for birth weight. Pediatr Infect Dis (1983) 0.83
Outbreak of poliomyelitis in Gizan, Saudi Arabia: cocirculation of wild type 1 polioviruses from three separate origins. J Infect Dis (1997) 0.83
Mumps surveillance--United States, 1988-1993. MMWR CDC Surveill Summ (1995) 0.83
[The risks of transmitting viral hepatitis in a section of the city of Bucharest]. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol (1989) 0.82
Evaluation of a single dose of diphtheria toxoid among adults in the Republic of Georgia, 1995: immunogenicity and adverse reactions. J Infect Dis (2000) 0.82
Commentary: the unfolding story of global poliomyelitis eradication. J Infect Dis (1997) 0.82
Using cost-effectiveness analysis to evaluate targeting strategies: the case of vitamin A supplementation. Health Policy Plan (1997) 0.82
Status of poliomyelitis eradication in Europe and the Central Asian republics of the former Soviet Union. J Infect Dis (1997) 0.81
Measles, mumps, and rubella vaccines. Infect Dis Clin North Am (1990) 0.81
Widespread paralytic poliomyelitis in Pakistan: A case-control study to determine risk factors and implications for poliomyelitis eradication. J Infect Dis (2000) 0.80
Sequential and combined use of inactivated and oral poliovirus vaccines: Dolj District, Romania, 1992-1994. J Infect Dis (1997) 0.80
Prevention of Haemophilus influenzae type b infections in day care: a public health perspective. Rev Infect Dis (1986) 0.80
Attributable risk of DTP (diphtheria and tetanus toxoids and pertussis vaccine) injection in provoking paralytic poliomyelitis during a large outbreak in Oman. J Infect Dis (1992) 0.79
Major subtypes of invasive Haemophilus influenzae from 1983 to 1985 in Atlanta, Ga. J Clin Microbiol (1990) 0.79
Increased immunogenicity of oral poliovirus vaccine administered in mass vaccination campaigns compared with the routine vaccination program in Jordan. J Infect Dis (1997) 0.79
Assessment of Guillain-Barré syndrome mortality and morbidity in the United States: implications for acute flaccid paralysis surveillance. J Infect Dis (1997) 0.79